Economy

How Have Alexion Pharmaceuticals, Inc. (ALXN) Earnings Estimates Changed?

The analysts offering 12 month price targets for Alexion Pharmaceuticals, Inc. have a median target of $166.5, with a high estimate of $180 and a low estimate of $122. The Fort Washington Investment Advisors Inc holds 4,593 shares with $559,000 value, down from 7,193 last quarter.

Alexion Pharmaceuticals, Inc is a biopharmaceutical company. About 1.74 million shares traded.

About 6.41M shares traded.

Alexion Pharmaceuticals (NASDAQ:ALXN) opened at 118.89 on Monday. It has underperformed by 34.82% the S&P500. The relative volume of the stock is 3.05, while its market cap is $26.68 Billion. The Firm operates in two divisions: Insurance, and Real estate and corporate. The Company is focused on the development and commercialization of therapeutic products. The stock's quarterly performance represents pessimistic momentum of -6.79 percent. Apg Asset Nv holds 0.01% or 55,932 shares. Assenagon Asset Management S.A. now owns 884,150 shares of the biopharmaceutical company's stock valued at $124,037,000 after buying an additional 864,967 shares during the last quarter.

In the market the company is trading down since yesterday's close of $119.66. Investors measure stock performance on the basis of a company's earnings power.

Since June 14, 2017, it had 4 insider buys, and 1 sale for $235.75 million activity. Another trade for 10,000 shares valued at $1.17M was made by HANTSON LUDWIG on Wednesday, June 14. In this case performance of tends to percentage rate of return for a stock for a given time frame.

State Treasurer State of MI cut its stake in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Taurus Asset Mngmt Ltd Co invested in 0.35% or 18,500 shares.

Understanding Profitability at Alexion Pharmaceuticals, Inc. (ALXN) was a Moderate Buy - from a survey of 15 analysts.

07/28/2017 - Alexion Pharmaceuticals, Inc. was upgraded to "outperform" by analysts at Oppenheimer. PARVEN ALVIN S sold $97,511 worth of stock or 835 shares.

Investors sentiment increased to 1.37 in Q2 2017.

Beta values for the above stocks are 1.87, 1.27, 0.00. Wexford Capital Lp, a Connecticut-based fund reported 2,900 shares.

Shares of Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. has a 50 day moving average of 139.62 and a 200 day moving average of 128.54. Alexion Pharmaceuticals had a return on equity of 12.55% and a net margin of 14.57%. Cwm Ltd Llc holds 0% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) have caught the attention of investors. D Scott Neal stated it has 1,200 shares. Finally, Zacks Investment Research cut shares of Alexion Pharmaceuticals from a "hold" rating to a "strong sell" rating in a research note on Wednesday, November 2nd. (NASDAQ:ALXN). Macquarie Grp Limited holds 131,994 shares. Mariner Wealth Advsrs Ltd Liability reported 5,073 shares. Panagora Asset Management owns 9,472 shares. 2,000 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Mckinley Carter Wealth Service invested in 2,316 shares.

06/23/2017 - Alexion Pharmaceuticals, Inc. had its "neutral" rating reiterated by analysts at Robert W. Baird. (NASDAQ:ALXN). Keybank Association Oh reported 0% in Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. (ALXN) is expected to post revenue of $885.65 Million in the current quarter, according to consensus of 17 analysts.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 1.9 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. Therefore 79% are positive. Alexion Pharmaceuticals Inc. has $257 highest and $82 lowest target. They now have a Dollars 170 price target on the stock.

06/15/2017 - Alexion Pharmaceuticals, Inc. had its "outperform" rating reiterated by analysts at Credit Suisse. The stock has "Buy" rating by Citigroup on Tuesday, September 20. As per Tuesday, March 29, the company rating was maintained by Citigroup. More interesting news about Alexion Pharmaceuticals, Inc. Royal Bank Of Canada initiated coverage on Alexion Pharmaceuticals in a research note on Thursday, September 14th. FBR Capital has "Underperform" rating and $82 target. Guggenheim initiated the shares of CPN in report on Friday, January 29 with "Buy" rating. The company was maintained on Thursday, July 27 by Jefferies. Penserra Capital Management LLC now owns 1,248 shares of the biopharmaceutical company's stock worth $151,000 after acquiring an additional 144 shares in the last quarter. The firm earned "Buy" rating on Tuesday, August 25 by Deutsche Bank. The rating was downgraded by Morgan Stanley on Monday, February 6 to "Equal-Weight". Virtus ETF Advisers LLC now owns 4,745 shares of the biopharmaceutical company's stock worth $581,000 after buying an additional 598 shares during the last quarter.



Like this

loading...
loading...

Latest


02 November 2017
Blue Apron sales beat expectations, shares jump
In the third quarter, Blue Apron reported a loss of 47 cents a share, missing the average analyst estimate of a loss of 43 cents. In an attempt to further trim costs, Blue Apron in October said it would cut its workforce by 6 percent.

02 November 2017
Gilead Sciences, Inc. (NASDAQ:GILD) Position Trimmed by Cadence Capital Management LLC
Appleton Prtnrs Ma holds 0.18% of its portfolio in Crown Castle International Corp. (REIT) (NYSE:CCI) for 10,915 shares. Gilead Sciences's revenue was down 13.2% compared to the same quarter a year ago . (NASDAQ: GILD ) for 301,497 shares.

02 November 2017
Stamps.com Inc. (STMP) Holdings Increased by State Street Corp
The stock has "Buy" rating by Singular Research on Monday, November 9. ( NASDAQ:QCOM ), 13 have Buy rating, 1 Sell and 21 Hold. The Company's platform enables people to view, share and collaborate on content, across various file formats and media types.

02 November 2017
Scorpio Tankers' (STNG) "Buy" Rating Reaffirmed at Jefferies Group LLC
Looking at some alternate time periods, the 12 month price index is 1.16841, the 24 month is 1.36724, and the 36 month is 1.4256. Looking further, the MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.

02 November 2017
Meet the world's 10 most powerful women
The rankings are based on money, media presence, influence, and impact . Angela Merkel is still the most powerful woman in the world.

02 November 2017
Karnataka government has 'broken all records' in corruption: Amit Shah
With this, the BJP will officially launch the campaign of the party for the 2018 assembly elections in the state. Shah's remarks come amid a raging debate between the state government and the opposition BJP over Tipu Sultan.

02 November 2017
England: Tammy Abraham, Joe Gomez & Ruben Loftus-Cheek called up
And Chelsea duo Jay DaSilva and Ike Ugbo have been named in the England Under-20 squad to play Germany along with Fulham's Adetayo Edun.

02 November 2017
Dairy Queen restaurants to close after franchisee bankruptcy filing
But Hurricane Harvey also had a negative impact on business, Vasari said. Twenty-two restaurants have already closed, nine more are scheduled to.

02 November 2017
Pakistani woman kills 17 family members to escape arranged marriage
But cases of poisoning related to cases of forced marriages, still a common practice in the country, are not uncommon. But Bibi was desperately unhappy with the man she had been matched with and was, in fact, in love with someone else.

02 November 2017
Letting fee ban laws unveiled by Government
Require Trading Standards to enforce the ban and to make provision for tenants to be able to recover unlawfully charged fees. This latest action aims to help improve transparency, affordability and competition in the private rental market.